Tag: LHON

Chiesi’s Raxone recommended for use within NHS Wales

by Lucy Parsons | Apr 27, 2021 | News | 0

Medicine recommended for the treatment of visual impairment in Leber’s Hereditary Optic Neuropathy

GenSight Biologics seeks EU approval for gene therapy

by Lucy Parsons | Sep 16, 2020 | News | 0

Lumevoq is designed to treat vision loss associated with Leber Hereditary Optic Neuropathy

Santhera’s Raxone fails in MS trial

by Selina McKee | Mar 6, 2018 | News | 0

Santhera has been hit with more bad news regarding its flagship mitochondrial disease therapy idebenone, after it failed to hit targets in a trial assessing its potential in multiple sclerosis.

Three new medicines cleared for use by NHS Scotland

by Selina McKee | May 9, 2017 | News | 0

The Scottish Medicines Consortium has endorsed three medicines for routine use by NHS Scotland, offering new options to treat a rare eye disease, lupus and infertility.